Colin Eldred

Bromobenzofurans : a new class of potent, non-peptide antagonists of angiotensin II

David Middlemiss, G.M. Drew, Barry C. Ross et al. · Bioorganic & Medicinal Chemistry Letters · 1991 · 50 citations

Molecular Pharmacology, Medicinal Chemistry, Angiotensin Ii +9

Synthesis and applications to asymmetric catalysis of a series of mono- and bis(diazaphospholidine) ligands

Donald Smyth, Heather Tye, Colin Eldred et al. · Journal of the Chemical Society Perkin Transactions 1 · 2001 · 47 citations

Cross-coupling Reaction, C–n Bonds, Engineering +11

Orally Active Non-Peptide Fibrinogen Receptor (GpIIb/IIIa) Antagonists: Identification of 4-[4-[4-(Aminoimino methyl)phenyl]-1-piperazinyl]-1- piperidineacetic Acid as a Long-Acting, Broad-Spectrum Antithrombotic Agent

Colin Eldred, Brian Evans, Sean J. Hindley et al. · Journal of Medicinal Chemistry · 1994 · 45 citations

Immunology, Altmetric Attention Score, Peptide Science +20

Synthesis and applications of a new class of phosphorus donor ligands for asymmetric catalysis

Heather Tye, Donald Smyth, Colin Eldred et al. · Chemical Communications · 1997 · 38 citations

Engineering, Allylic Substitution Reaction, Organic Chemistry +17

Addressing species specific metabolism and solubility issues in a quinoline series of oral PDE4 inhibitors

Christopher J. Lunniss, Colin Eldred, Natalie E. Aston et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 35 citations · Full text

Species Specific Metabolism, Medicinal Chemistry, Biochemistry +9